We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$31.8B
AUM Growth
+$145M
Cap. Flow
-$898M
Cap. Flow %
-2.82%
Top 10 Hldgs %
5.32%
Holding
3,043
New
137
Increased
1,222
Reduced
1,432
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 11.47%
2 Healthcare 11.35%
3 Consumer Discretionary 10.7%
4 Financials 10.46%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SES
2801
DELISTED
Synthesis Energy Systems Inc.
SES
$22K ﹤0.01%
326
CTIC
2802
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$22K ﹤0.01%
6,359
-456
-7% -$2.09K
BBDO icon
2803
Banco Bradesco
BBDO
$36.4B
$21K ﹤0.01%
4,143
-2
-0% -$9
MVIS icon
2804
Microvision
MVIS
$93.2M
$21K ﹤0.01%
822
AMPE
2805
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$21K ﹤0.01%
54
+5
+10% +$5.46K
ALSK
2806
DELISTED
Alaska Communications Systems
ALSK
$21K ﹤0.01%
12,088
ZN
2807
DELISTED
Zion Oil & Gas, Inc.
ZN
$21K ﹤0.01%
15,284
HTM
2808
DELISTED
U.S. Geothermal Inc.
HTM
$21K ﹤0.01%
4,309
NWY
2809
DELISTED
New York & Co Inc
NWY
$20K ﹤0.01%
13,595
GROW icon
2810
US Global Investors
GROW
$35.5M
$19K ﹤0.01%
10,911
CVO
2811
DELISTED
Cenevo, Inc.
CVO
$19K ﹤0.01%
2,925
VXRT
2812
DELISTED
Vaxart
VXRT
$18K ﹤0.01%
1,145
AVEO
2813
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$18K ﹤0.01%
1,859
CARM
2814
DELISTED
Carisma Therapeutics
CARM
$17K ﹤0.01%
517
IRD
2815
Opus Genetics
IRD
$306M
$17K ﹤0.01%
144
CIE
2816
DELISTED
Cobalt International Energy, Inc
CIE
$17K ﹤0.01%
859
-3,759
-81% -$145K
LUNA
2817
DELISTED
Luna Innovations Incorporated
LUNA
$17K ﹤0.01%
13,349
SPRT
2818
DELISTED
support.com, Inc.
SPRT
$16K ﹤0.01%
6,167
CPRX
2819
DELISTED
Catalyst Pharmaceutical
CPRX
$15K ﹤0.01%
21,595
-1,760
-8% -$1.42K
EGY icon
2820
Vaalco Energy
EGY
$570M
$15K ﹤0.01%
13,836
GSAT icon
2821
Globalstar
GSAT
$10.7B
$15K ﹤0.01%
803
+97
+14% +$2.58K
BIOL
2822
DELISTED
Biolase, Inc.
BIOL
$15K ﹤0.01%
1
CMLS
2823
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$15K ﹤0.01%
5,913
-416
-7% -$1.2K
MTEM
2824
DELISTED
Molecular Templates, Inc.
MTEM
$15K ﹤0.01%
139
-8
-5% -$573
LITS
2825
Lite Strategy Inc
LITS
$32.8M
$14K ﹤0.01%
530

Similar funds

Guggenheim Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Guggenheim Capital held 3,043 positions worth $31.8B, up 0.46% from $31.7B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Guggenheim Capital's Q2 2016 filing shows 137 new, 1,222 increased, 1,432 reduced and 170 closed positions. Its largest new stake was S&P Global: 471,834 shares worth $50.6M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $66.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2016 buy was S&P Global: 471,834 shares worth $50.6M.
  • Guggenheim Capital added most to Global Payments in Q2 2016, an estimated $45.5M increase.
  • Guggenheim Capital's biggest Q2 2016 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $66.9M.
  • Guggenheim Capital fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $51.1M.
  • Guggenheim Capital's ten largest holdings make up 5.3% of its $31.8B portfolio in Q2 2016.
  • Guggenheim Capital opened 137 new positions and closed 170 in Q2 2016.
  • Guggenheim Capital's portfolio value rose 0.46% quarter-over-quarter to $31.8B.

Based on Guggenheim Capital's 13F filing for Q2 2016, filed 15 Aug 2016.